Craxi A - Search Results

1

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort.

Almasio PL, Licata A, Maida M, Macaluso FS, Costantino A, Alessi N, Grimaudo S, Accardi G, Caruso C, Craxi A. Almasio PL, et al. Among authors: craxi a. Hepat Mon. 2016 Oct 16;16(11):e31681. doi: 10.5812/hepatmon.31681. eCollection 2016 Nov. Hepat Mon. 2016. PMID: 28070198 Free PMC article.

2

Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.

Di Marco V, Ferraro D, Almasio P, Vaccaro A, Parisi P, Cappello M, Cino N, Di Stefano R, Craxì A. Di Marco V, et al. Among authors: craxi a. J Viral Hepat. 2002 Sep;9(5):354-9. doi: 10.1046/j.1365-2893.2002.00370.x. J Viral Hepat. 2002. PMID: 12225330 Clinical Trial.

3

Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract.

Cabibi D, Licata A, Barresi E, Craxì A, Aragona F. Cabibi D, et al. Among authors: craxi a. Pathol Res Pract. 2003;199(2):65-70. doi: 10.1078/0344-0338-00356. Pathol Res Pract. 2003. PMID: 12747467 Free article.

4

IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection.

Lio D, Caruso C, Di Stefano R, Colonna Romano G, Ferraro D, Scola L, Crivello A, Licata A, Valenza LM, Candore G, Craxì A, Almasio PL. Lio D, et al. Among authors: craxi a. Hum Immunol. 2003 Jul;64(7):674-80. doi: 10.1016/s0198-8859(03)00080-6. Hum Immunol. 2003. PMID: 12826369

5

Clinical trial results of peginterferons in combination with ribavirin.

Craxi A, Licata A. Craxi A, et al. Semin Liver Dis. 2003;23 Suppl 1:35-46. doi: 10.1055/s-2003-41633. Semin Liver Dis. 2003. PMID: 12934167 Review.

6

When and how to treat acute hepatitis C?

Licata A, Di Bona D, Schepis F, Shahied L, Craxí A, Cammà C. Licata A, et al. Among authors: craxi a. J Hepatol. 2003 Dec;39(6):1056-62. doi: 10.1016/s0168-8278(03)00461-6. J Hepatol. 2003. PMID: 14642626

7

Interferon therapy: the other face of the medal.

Licata A, Craxì A. Licata A, et al. Among authors: craxi a. Ann Ital Med Int. 2004 Jan-Mar;19(1):5-7. Ann Ital Med Int. 2004. PMID: 15176703 No abstract available.

8

Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine.

Di Marco V, Marzano A, Lampertico P, Andreone P, Santantonio T, Almasio PL, Rizzetto M, Craxì A; Italian Association for the Study of the Liver (AISF) Lamivudine Study Group, Italy. Di Marco V, et al. Among authors: craxi a. Hepatology. 2004 Oct;40(4):883-91. doi: 10.1002/hep.20381. Hepatology. 2004. PMID: 15382125

9

[Iron overload disease: recent findings].

Licata A, Brucato V, Di Marco V, Barbaria F, Craxì A. Licata A, et al. Among authors: craxi a. Ann Ital Med Int. 2004 Jul-Sep;19(3):145-54. Ann Ital Med Int. 2004. PMID: 15529941 Review. Italian.

10

Treatment of hepatitis C: critical appraisal of the evidence.

Cammà C, Licata A, Cabibbo G, Latteri F, Craxì A. Cammà C, et al. Among authors: craxi a. Expert Opin Pharmacother. 2005 Mar;6(3):399-408. doi: 10.1517/14656566.6.3.399. Expert Opin Pharmacother. 2005. PMID: 15794731 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

563 results

Search Page